Quarterly report · Q2
2342.TEDINET S100S7OP
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥11.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥89m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥135m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥95m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥199m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥204m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥94m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥157m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥48m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥410m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥55m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥42m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥55m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥10.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥10.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥10.7bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.1bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥366m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥696m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥129m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥216m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥601m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥47m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥485m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥65m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥2.87 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.76 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.32 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.26 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.79 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.4% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2023-09-30 | ¥450,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥108m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥981m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥978m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥27m |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥628,000 |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥223m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥196m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-09-30 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥111m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥3m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥153m |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥187,000 |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥92m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥246m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Other comprehensive income | Prior1YTDDuration | 12087000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 28415000 | JPY |
| Comprehensive income | Prior1YTDDuration | 66611000 | JPY |
| Comprehensive income | CurrentYTDDuration | 70607000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 66978000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 76879000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -367000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -6272000 | JPY |
| Income before income taxes | Prior1YTDDuration | 156552000 | JPY |
| Income before income taxes | CurrentYTDDuration | 94083000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 58578000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 47348000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 47756000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | － | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 29277000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 22281000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 106000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 375000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 30483000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 44923000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -378000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -147000 | JPY |
| Surrender value of insurance ope cf | Prior1YTDDuration | -155376000 | JPY |
| Surrender value of insurance ope cf | CurrentYTDDuration | － | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 13073000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 24297000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 63966000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -172520000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -533459000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -492186000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 181969000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 234518000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -156848000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -28040000 | JPY |
| Increase decrease in advances received ope cf | Prior1YTDDuration | -175307000 | JPY |
| Increase decrease in advances received ope cf | CurrentYTDDuration | -350517000 | JPY |
| Other net ope cf | Prior1YTDDuration | 37783000 | JPY |
| Other net ope cf | CurrentYTDDuration | 55505000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -401821000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -520077000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 188000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 145000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -13063000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -24297000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -291364000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -55566000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 10247000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | 234250000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -695814000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -365546000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |